Global Information
회사소개 | 문의 | 위시리스트

세계의 중추신경계 의약품 시장 : 진통제, 항파킨슨병 약제, 마취제, 항간질약, 기타

Central Nervous System Drugs Global Market Report 2019

리서치사 The Business Research Company
발행일 2019년 01월 상품 코드 531325
페이지 정보 영문 300 Pages
가격
US $ 4,000 ₩ 4,779,000 PDF by E-mail (Single User License)
US $ 6,000 ₩ 7,169,000 PDF by E-mail (Site License)
US $ 8,000 ₩ 9,559,000 PDF by E-mail (Enterprise License)


세계의 중추신경계 의약품 시장 : 진통제, 항파킨슨병 약제, 마취제, 항간질약, 기타 Central Nervous System Drugs Global Market Report 2019
발행일 : 2019년 01월 페이지 정보 : 영문 300 Pages

세계의 중추신경계 의약품 시장을 조사했으며, 시장 정의와 개요, 시장에 대한 각종 영향요인 분석, 약제 부문·지역·국가별 동향과 시장 규모 추이 및 예측, 거시경제 요인·헬스케어 시장 전체·각종 산업 지표와의 비교, 경쟁 환경, 기업 개요 등을 정리하여 전해드립니다.

제1장 시장의 특징

제2장 시장 규모·성장률

  • 시장 성장 : 현재까지의 경위
    • 성장 촉진요인
    • 성장 억제요인
  • 시장 성장 : 예측
    • 성장 촉진요인
    • 성장 억제요인

제3장 PESTLE 분석

제4장 고객 정보

제5장 중추신경계 의약품 시장 분석 : 세분화별

  • 세계 시장의 실적 : 부문별
    • 진통제
    • 항파킨슨병 약제
    • 마취제
    • 항간질약
    • 기타
  • 세계 시장의 추이와 예측 : 부문별
  • 시장 동향·전략

제6장 중추신경계 의약품 시장 분석 : 지역·국가별 분석

  • 세계 시장의 실적 : 지역별
  • 세계 시장의 추이와 예측 : 지역별
  • 시장 실적 : 국가별
  • 시장의 추이와 예측 : 국가별
  • 세계 의약품 시장의 실적 : 부문·지역별
  • 세계 의약품 시장의 실적 : 부문·국가별

제7장 거시경제 요인과 시장의 비교

  • 시장 규모의 GDP에서 차지하는 비율
  • 1인당 평균 지출액

제8장 거시경제 요인과 시장의 비교 : 국가별

  • 시장 규모의 GDP에서 차지하는 비율 : 국가별
  • 1인당 평균 지출액 : 국가별

제9장 산업 지표와 시장의 비교

  • 세계의 약제사 수 : 국가별
  • 시장 매출 vs 약제사 수 : 국가별
  • 세계의 의약품회사 수 : 국가별
  • 시장 매출 vs 의약품회사 수 : 국가별
  • 세계의 R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 시장 매출 vs R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 세계의 제네릭 & 브랜드 매출 비율 : 국가별
  • 시장 매출 vs 제네릭 & 브랜드 매출 비율 : 국가별
  • 파킨슨병 환자 수 : 국가별
  • 세계의 정신과 의사수 : 국가별
  • 시장 매출 vs 정신과 의사수 : 국가별
  • 세계의 일반 개업의 수 : 국가별
  • 시장 매출 vs 일반 개업의 수 : 국가별

제10장 아시아태평양 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 중국
  • 인도
  • 일본
  • 호주

제11장 서유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인

제12장 동유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 러시아

제13장 북미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 미국

제14장 남미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 브라질

제15장 중동 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제16장 아프리카 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제17장 경쟁 환경

  • 기업 개요
  • Pfizer Inc.
  • Biogen Idec
  • Novartis Ag
  • Otsuka
  • Teva Pharmaceuticals

제18장 주요 M&A : 중추신경계 의약품 시장

제19장 시장 배경 : 의약품 시장

제20장 의약품 산업의 파이낸셜 마진

제21장 부록

KSA 17.08.07

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Central Nervous System Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the central nervous system drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Central Nervous System Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, central nervous system drugs indicators comparison.

Scope

Markets Covered: Nervous System Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs

Companies Mentioned: Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG

Metrics Covered: Parkinson Prevalence Rate, Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, central nervous system drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Central Nervous System Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis

  • 9.1. Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation

  • 10.1. Global Central Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Nervous System Drugs
    • 10.1.2. Analgesics
    • 10.1.3. Anti-Parkinson drugs
    • 10.1.4. Anesthetics
    • 10.1.5. Anti-Epileptics
    • 10.1.6. Other CNS drugs

11. Central Nervous System Drugs Market Metrics

  • 11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Central Nervous System Drugs Market

  • 12.1. Asia-Pacific Central Nervous System Drugs Market Overview
  • 12.2. Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics
    • 12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
    • 12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries
  • 12.6. Asia-Pacific Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
    • 12.7.1. China Central Nervous System Drugs Market
      • 12.7.1.1. China Central Nervous System Drugs Market Overview
      • 12.7.1.2. China Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Central Nervous System Drugs Market
      • 12.7.2.1. Australia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Central Nervous System Drugs Market
      • 12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Central Nervous System Drugs Market
      • 12.7.4.1. India Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Central Nervous System Drugs Market
      • 12.7.5.1. Indonesia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Central Nervous System Drugs Market
      • 12.7.6.1. Japan Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Central Nervous System Drugs Market
      • 12.7.7.1. Malaysia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Central Nervous System Drugs Market
      • 12.7.8.1. New Zealand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Central Nervous System Drugs Market
      • 12.7.9.1. Philippines Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Central Nervous System Drugs Market
      • 12.7.10.1. Singapore Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Central Nervous System Drugs Market
      • 12.7.11.1. South Korea Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Central Nervous System Drugs Market
      • 12.7.12.1. Thailand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Central Nervous System Drugs Market
      • 12.7.13.1. Vietnam Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Central Nervous System Drugs Market

  • 13.1. Western Europe Central Nervous System Drugs Market Overview
  • 13.2. Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Central Nervous System Drugs Market Metrics
    • 13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Western Europe Countries
    • 13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries
  • 13.6. Western Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Central Nervous System Drugs Market: Country Analysis
    • 13.7.1. Austria Central Nervous System Drugs Market
      • 13.7.1.1. Austria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Central Nervous System Drugs Market
      • 13.7.2.1. Belgium Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Central Nervous System Drugs Market
      • 13.7.3.1. Denmark Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Central Nervous System Drugs Market
      • 13.7.4.1. Finland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Central Nervous System Drugs Market
      • 13.7.5.1. France Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Central Nervous System Drugs Market
      • 13.7.6.1. Germany Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Central Nervous System Drugs Market
      • 13.7.7.1. Ireland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Central Nervous System Drugs Market
      • 13.7.8.1. Italy Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Central Nervous System Drugs Market
      • 13.7.9.1. Netherlands Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Central Nervous System Drugs Market
      • 13.7.10.1. Norway Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Central Nervous System Drugs Market
      • 13.7.11.1. Portugal Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Central Nervous System Drugs Market
      • 13.7.12.1. Spain Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Central Nervous System Drugs Market
      • 13.7.13.1. Sweden Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Central Nervous System Drugs Market
      • 13.7.14.1. Switzerland Central Nervous System Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Central Nervous System Drugs Market
      • 13.7.15.1. UK Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Central Nervous System Drugs Market

  • 14.1. Eastern Europe Central Nervous System Drugs Market Overview
  • 14.2. Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Central Nervous System Drugs Market Metrics
    • 14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
    • 14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries
  • 14.6. Eastern Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Central Nervous System Drugs Market,
      • 14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Central Nervous System Drugs Market
      • 14.7.2.1. Poland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Central Nervous System Drugs Market
      • 14.7.3.1. Romania Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Central Nervous System Drugs Market
      • 14.7.4.1. Russia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Central Nervous System Drugs Market

  • 15.1. North America Central Nervous System Drugs Market Overview
  • 15.2. North America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Central Nervous System Drugs Market Metrics
    • 15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, North America Countries
    • 15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries
  • 15.6. North America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Central Nervous System Drugs Market: Country Analysis
    • 15.7.1. Canada Central Nervous System Drugs Market
      • 15.7.1.1. Canada Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Central Nervous System Drugs Market
      • 15.7.2.1. Mexico Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Central Nervous System Drugs Market
      • 15.7.3.1. USA Central Nervous System Drugs Market Overview
      • 15.7.3.2. USA Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Central Nervous System Drugs Market

  • 16.1. South America Central Nervous System Drugs Market Overview
  • 16.2. South America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Central Nervous System Drugs Market Metrics
    • 16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, South America Countries
    • 16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries
  • 16.6. South America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Central Nervous System Drugs Market: Country Analysis
    • 16.7.1. Argentina Central Nervous System Drugs Market
      • 16.7.1.1. Argentina Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Central Nervous System Drugs Market
      • 16.7.2.1. Brazil Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Central Nervous System Drugs Market
      • 16.7.3.1. Chile Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Central Nervous System Drugs Market
      • 16.7.4.1. Colombia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Central Nervous System Drugs Market
      • 16.7.5.1. Peru Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Central Nervous System Drugs Market
      • 16.7.6.1. Venezuela Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Central Nervous System Drugs Market

  • 17.1. Middle East Central Nervous System Drugs Market Overview
  • 17.2. Middle East, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Central Nervous System Drugs Market Metrics
    • 17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Middle East Countries
    • 17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries
  • 17.6. Middle East Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Central Nervous System Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Central Nervous System Drugs Market
      • 17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Central Nervous System Drugs Market
      • 17.7.2.1. Israel Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Central Nervous System Drugs Market
      • 17.7.3.1. Turkey Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Central Nervous System Drugs Market
      • 17.7.4.1. UAE Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Central Nervous System Drugs Market

  • 18.1. Africa Central Nervous System Drugs Market Overview
  • 18.2. Africa, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Central Nervous System Drugs Market Metrics
    • 18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Africa Countries
    • 18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries
  • 18.6. Africa Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Central Nervous System Drugs Market: Country Analysis
    • 18.7.1. Egypt Central Nervous System Drugs Market
      • 18.7.1.1. Egypt Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Central Nervous System Drugs Market
      • 18.7.2.1. Nigeria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Central Nervous System Drugs Market
      • 18.7.3.1. South Africa Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

19. Central Nervous System Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Biogen Inc
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.1.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. F. Hoffmann-La Roche Ltd
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.2.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Johnson & Johnson
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.3.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Pfizer Inc
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.4.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.5.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Central Nervous System Drugs Market In 2022- Growth Countries
  • 22.2. Global Central Nervous System Drugs Market In 2022- Growth Segments
  • 22.3. Global Central Nervous System Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top
전화 문의
F A Q